Back to ADAGE CAPITAL PARTNERS GP, L.L.C.

RPRX
Showing 8 of 24 quarters

Position history for ADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in ROYALTY PHARMA PLC

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 7.5M shares of RPRX (ROYALTY PHARMA PLC), worth $358.8M as of 2026-Q1. The position was decreased (-36.3% shares). RPRX represents 0.6% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$358.8M

Current Shares

7.5M

Total Value Change

+$70.6M

Total Shares Change

-3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
7.5M
-36.3%
$358.8M0.6%$47.48
0
2025-Q4
Decreased
11.7M
-1.9%
$453.7M0.7%$38.99
0
2025-Q3
Increased
12M
+99.4%
$422.1M0.7%$35.05
71
2025-Q2
Decreased
6M
-4.0%
$216.2M0.4%$35.46
0
2025-Q1
Decreased
6.3M
-63.2%
$194.6M0.4%$30.80
0
2024-Q4
Increased
17M
+42.6%
$432.9M0.8%$24.70
59
2024-Q3
Increased
11.9M
+8.8%
$336.6M0.6%$27.29
48
2024-Q2
Increased
10.9M
+1.1%
$288.3M0.5%$25.32
44

Other major holders of RPRX: MORGAN STANLEY, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used